These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31599501)

  • 1. The Potential Procognitive Effects of Modafinil in Major Depressive Disorder: A Systematic Review.
    Vaccarino SR; McInerney SJ; Kennedy SH; Bhat V
    J Clin Psychiatry; 2019 Oct; 80(6):. PubMed ID: 31599501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
    Goss AJ; Kaser M; Costafreda SG; Sahakian BJ; Fu CH
    J Clin Psychiatry; 2013 Nov; 74(11):1101-7. PubMed ID: 24330897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procognitive Effects of Antidepressants and Other Therapeutic Agents in Major Depressive Disorder: A Systematic Review.
    Blumberg MJ; Vaccarino SR; McInerney SJ
    J Clin Psychiatry; 2020 Jul; 81(4):. PubMed ID: 32726521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review.
    Saavedra-Velez C; Yusim A; Anbarasan D; Lindenmayer JP
    J Clin Psychiatry; 2009 Jan; 70(1):104-12. PubMed ID: 19026265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label study of adjunctive modafinil in patients with sedation related to serotonergic antidepressant therapy.
    Schwartz TL; Azhar N; Cole K; Hopkins G; Nihalani N; Simionescu M; Husain J; Jones N
    J Clin Psychiatry; 2004 Sep; 65(9):1223-7. PubMed ID: 15367049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study.
    DeBattista C; Doghramji K; Menza MA; Rosenthal MH; Fieve RR;
    J Clin Psychiatry; 2003 Sep; 64(9):1057-64. PubMed ID: 14628981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for chronic cognitive impairment in traumatic brain injury.
    Dougall D; Poole N; Agrawal N
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009221. PubMed ID: 26624881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of dopaminergic agents in improving quality of life in major depressive disorder.
    IsHak WW; Davis M; Jeffrey J; Balayan K; Pechnick RN; Bagot K; Rapaport MH
    Curr Psychiatry Rep; 2009 Dec; 11(6):503-8. PubMed ID: 19909674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between neurocognitive and psychosocial functioning in major depressive disorder: a systematic review.
    Evans VC; Iverson GL; Yatham LN; Lam RW
    J Clin Psychiatry; 2014 Dec; 75(12):1359-70. PubMed ID: 25551235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modafinil in the treatment of depression].
    Videbech P
    Ugeskr Laeger; 2012 Feb; 174(6):348-51. PubMed ID: 22310006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications.
    Sevy S; Rosenthal MH; Alvir J; Meyer S; Visweswaraiah H; Gunduz-Bruce H; Schooler NR
    J Clin Psychiatry; 2005 Jul; 66(7):839-43. PubMed ID: 16013898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive remission: a novel objective for the treatment of major depression?
    Bortolato B; Miskowiak KW; Köhler CA; Maes M; Fernandes BS; Berk M; Carvalho AF
    BMC Med; 2016 Jan; 14():9. PubMed ID: 26801406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of Modafinil in Co-existing Major Depression and ErectileDysfunction: A Case Report].
    Karaş H; Kaşer M
    Turk Psikiyatri Derg; 2019; 30(2):142-144. PubMed ID: 31487380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychostimulants in moderate to severe affective disorder: a systematic review of randomized controlled trials.
    Abbasowa L; Kessing LV; Vinberg M
    Nord J Psychiatry; 2013 Dec; 67(6):369-82. PubMed ID: 23293898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognition as a target in major depression: new developments.
    Solé B; Jiménez E; Martinez-Aran A; Vieta E
    Eur Neuropsychopharmacol; 2015 Feb; 25(2):231-47. PubMed ID: 25640673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modafinil as adjunctive therapy in depressed outpatients.
    Nasr S
    Ann Clin Psychiatry; 2004; 16(3):133-8. PubMed ID: 15517845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring cognitive function in MDD: emerging assessment tools.
    Russo M; Mahon K; Burdick KE
    Depress Anxiety; 2015 Apr; 32(4):262-9. PubMed ID: 25421437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.
    Fava M; Thase ME; DeBattista C; Doghramji K; Arora S; Hughes RJ
    Ann Clin Psychiatry; 2007; 19(3):153-9. PubMed ID: 17729016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Rosenblat JD; Kakar R; McIntyre RS
    Int J Neuropsychopharmacol; 2015 Jul; 19(2):. PubMed ID: 26209859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression.
    Papakostas GI; Martinson MA; Fava M; Iovieno N
    J Clin Psychiatry; 2016 May; 77(5):e619-24. PubMed ID: 27249092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.